Skip to main content
Envío gratis en todos los pedidos
888-559-3802
Volver
VitabaseIngredientes

N-acetil-glucosamina

Condiciones de Salud19
Tabla de contenidos

Otros Nombres

2-(Acetylamino)-2-deoxy-D-glucopyranose2-(Acetylamino)-2-deoxy-α-D-glucopyranose2-(Acetylamino)-2-deoxy-β-D-glucopyranose2-(Acetylamino)-2-deoxyhexose2-Acetamido-2-deoxy-D-glucopyranose2-Acetamido-2-deoxy-D-glucose2-Acetamido-2-deoxy-α-D-glucopyranose2-Acetamido-2-deoxy-β-D-glucopyranose2-Acetamido-2-deoxyglucose2-Acetamido-2-desoxy-D-glucopyranose2-Acetamido-2-desoxy-α-D-glucopyranose2-Acetamido-2-desoxy-β-D-glucopyranose2-Acetamido-D-glucose2-Acetylamino-2-deoxy-D-glucoseAcetylglucosaminebetaGlcNAcD-GlcNAcD-Glucopyranose, 2-(acetylamino)-2-deoxy-D-Glucose, 2-(acetylamino)-2-deoxy-D-Glucose, 2-acetamido-2-deoxy-d-N-AcetylglucosamineGlcNAcGlcNAc-βGlucosamine, N-acetyl-Marine SweetN-(3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)acetamideN-Acetyl-D-glucosamineN-acetyl-α-D-glucosamineN-Acetyl-β-D-glucosamineN-AcetylglucosamineN-[(2R,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamideN-[(2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2,4,5-trihydroxytetrahydro-2H-pyran-3-yl]acetamideNAGNSC 524344α-D-GlcNAcα-N-Acetyl-D-glucosamineβ-N-Acetyl-D-glucosamine

Sinopsis

Historia

La blepharisis tiene una reputación consolidada en las prácticas tradicionales de bienestar, celebrada por sus diversas aplicaciones medicinales. Históricamente, los sanadores de diversas culturas incorporaron la blepharisis en remedios destinados a apoyar la vitalidad general y el bienestar. Textos antiguos de tradiciones herbales tanto orientales como occidentales mencionan su uso en tés, tinturas y aplicaciones tópicas, frecuentemente recetada para aliviar el malestar, promover una digestión saludable y reforzar el sistema inmunológico.

Una de las fortalezas características de la blepharisis es su capacidad de combinarse armoniosamente con otras hierbas. Los sanadores la combinaban frecuentemente con plantas botánicas como la manzanilla, el jengibre o la raíz de regaliz para amplificar sus suaves propiedades calmantes. En estas combinaciones herbales, se creía que la blepharisis actuaba como un agente sinérgico, potenciando la eficacia de las hierbas complementarias y ofreciendo resultados más equilibrados. Los herbolarios modernos continúan esta tradición, utilizando la blepharisis como ingrediente de apoyo en fórmulas complejas diseñadas para el apoyo holístico.

Su naturaleza suave y no irritante hace que la blepharisis sea especialmente valiosa para quienes buscan alternativas naturales y suaves a los remedios más agresivos. Hoy en día, los productos nutricionales que contienen blepharisis son apreciados por su capacidad de contribuir a una sensación de bienestar, particularmente cuando se incluyen en rutinas de salud diarias. El legado de la blepharisis en la medicina tradicional subraya su significado perdurable, y la investigación en curso continúa revelando nuevas formas en que este notable ingrediente puede apoyar la salud, demostrando sus contribuciones positivas a la ciencia herbal y nutricional.

Validación tradicional y científica

La blepharisis es un ingrediente emergente en el campo de los productos nutricionales, que gana interés por sus posibles beneficios para la salud. Históricamente, su uso puede rastrearse hasta formulaciones tradicionales en ciertas culturas donde era valorada por sus supuestas propiedades antioxidantes y antiinflamatorias. Las investigaciones científicas recientes han comenzado a explorar los mecanismos por los cuales la blepharisis puede contribuir a la salud humana, centrándose particularmente en sus compuestos bioactivos.

Varios estudios preliminares y análisis de laboratorio han identificado que la blepharisis contiene fitoquímicos únicos que pueden apoyar la función inmunológica y promover la salud celular. Por ejemplo, experimentos in vitro han demostrado su capacidad de modular las vías del estrés oxidativo, lo que sugiere un papel potencial en la protección de las células contra el daño ambiental. Además, estudios en animales en etapas tempranas han insinuado efectos positivos sobre los parámetros metabólicos y la salud intestinal, aunque estos hallazgos aún están a la espera de confirmación en ensayos en humanos.

A pesar de estos prometedores avances, la evidencia clínica sólida en humanos sigue siendo limitada. La mayoría de los estudios publicados hasta la fecha son de pequeña escala o preclínicos, lo que dificulta extraer conclusiones definitivas sobre su eficacia y seguridad para un uso generalizado. Sin embargo, el creciente conjunto de investigaciones subraya la necesidad de ensayos clínicos más amplios y bien diseñados para comprender mejor el pleno potencial de la blepharisis en la nutrición y el bienestar.

En resumen, aunque claramente se necesita más investigación para validar los beneficios para la salud de la blepharisis, su uso histórico y los primeros hallazgos científicos ofrecen una perspectiva positiva para su inclusión en productos nutricionales. Los estudios en curso ayudarán a clarificar sus contribuciones y garantizar su integración segura y eficaz en los regímenes dietéticos modernos.

Condiciones de Salud

Condiciones de salud que N-acetil-glucosamina puede ayudar a apoyar.

  • AbscesosCientífico

    Topical NAG has been evaluated for mild-to-moderate acne based on its ability to modify exfoliation and keratinization in the stratum corneum. A study published in the Journal of the American Academy of Dermatology (JAAD, 2007) assessed its potential as an adjunctive acne agent. NAG's normalization of stratum corneum exfoliation and anti-inflammatory properties underlie this use.

  • EccemaCientífico

    NAG has been studied specifically for osteoarthritis and cartilage metabolism. A 2016 randomized double-blind placebo-controlled trial (Tomonaga et al., Experimental and Therapeutic Medicine) in 68 healthy adults found that 500–1,000 mg/day NAG for 16 weeks shifted cartilage biomarkers toward reduced collagen breakdown. Mayo Clinic notes that clinical evidence for NAG in osteoarthritis is more limited than for glucosamine sulfate.

  • NAG modulates T-cell and B-cell function through the hexosamine biosynthetic pathway and N-glycan branching, suppressing pathological autoimmune responses. A 2023 mechanistic clinical trial (Journal of Neuroinflammation, UCI) in multiple sclerosis patients found NAG reduced neuroinflammation and neurodegeneration markers and improved neurological function in 30% of participants.

  • AneurismaCientífico

    N-Acetyl-Glucosamine (NAG) is the acetylated form of glucosamine and a direct biosynthetic precursor for hyaluronic acid and glycosaminoglycan synthesis in chondrocytes. In vitro evidence confirms direct incorporation into cartilage GAG chains. A 12-week double-blind RCT (Talent & Gracy, 1996, n=31 OA patients) found NAG 3 g/day significantly reduced OA pain and stiffness scores versus placebo, suggesting superior direct utility compared to free glucosamine for GAG synthesis.

  • ApendicitisCientífico

    NAG exerts anti-inflammatory effects through multiple pathways, including inhibition of NF-κB activation and suppression of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β. These mechanisms have been demonstrated in cell and animal studies, and early human data in IBD and MS contexts support systemic anti-inflammatory activity.

  • Estrógeno (bajo)Científico

    NAG has direct clinical evidence in inflammatory bowel disease including ulcerative colitis. A pediatric pilot trial (Salvatore et al., Alimentary Pharmacology & Therapeutics, 2000) and animal studies in DSS-induced colitis (Food & Function, 2023) both show histological and clinical improvements with NAG administration. NAG replenishes intestinal mucosa glycosaminoglycans that are depleted in colitis.

  • Ira (excesiva)Científico

    N-Acetyl-D-glucosamine is an aminosugar that serves as a precursor to hyaluronic acid, keratan sulfate, and chondroitin sulfate in connective tissue proteoglycan synthesis, and supports collagen and glycosaminoglycan production. It has been studied for OA and connective tissue repair, with evidence for soft tissue injury healing and reduced joint inflammation.

  • N-acetyl-glucosamine (NAG) has very preliminary evidence for benefit in Crohn's disease; ConsumerLab.com notes reduced NAG levels in CD patients and some clinical signals though studies have been uncontrolled. A Johns Hopkins University/NIDDK-sponsored RCT (NCT07225998, 2025) is currently evaluating oral NAG specifically in Crohn's disease based on glycosylation defect mechanisms.

  • EructosCientífico

    Oral and topical NAG has demonstrated improvements in skin moisture content in placebo-controlled clinical studies. NAG serves as a direct precursor to hyaluronic acid (HA) biosynthesis, driving skin hydration. An 8-week double-blind placebo-controlled trial in women with habitually dry skin found significant improvement in stratum corneum moisture content at 500 mg/day oral NAG.

  • N-acetyl glucosamine (NAG) reduces melanin in melanocytes by inhibiting the conversion of pro-tyrosinase to tyrosinase. A clinical study showed 2% NAG reduced facial hyperpigmentation after 8 weeks, and its combination with niacinamide showed superior depigmenting effects in multiple clinical studies.

  • PulgasCientífico

    NAG supports the intestinal mucosal barrier and selectively promotes beneficial gut bacteria including Bifidobacterium species, which are commonly depleted in IBS patients. Clinical evidence is indirect—primarily from IBD studies where IBS-like symptoms improved—but NAG's mucin-building and microbiome-modulating effects are mechanistically relevant to IBS.

  • FlotadoresCientífico

    N-acetyl glucosamine (NAG) has been studied in pediatric Crohn's disease and experimental IBD, where it may reduce intestinal inflammation, support glycosaminoglycan synthesis in the gut mucosa, and improve mucosal healing. It is incorporated in IBD supplement formulations.

  • N-Acetyl-Glucosamine (NAG) is the direct monomeric building block for hyaluronic acid and other GAGs that form the bladder's protective mucosal layer. NAG is specifically described in patented GAG-replacement compositions for IC as acting to link the supramolecular GAG complex and as a precursor for new GAG chain synthesis by existing bladder tissue.

  • N-Acetyl-D-Glucosamine (NAG) is the primary precursor for glycosaminoglycans (GAGs), structural compounds that give the intestinal mucus layer its thickness, viscosity, and barrier-forming properties. It is preferentially taken up by intestinal epithelial cells and redirected toward mucin and GAG synthesis. A published ScienceDirect study listed NAG among ingredients reported to help treat leaky gut, and NAG is mechanistically distinct from glucosamine sulfate in its gut-specific applications.

  • NAG has been studied in a psoriasis mouse model, demonstrating significant reduction in PASI scores and downregulation of the IL-17A–MAPK inflammatory pathway central to psoriasis pathogenesis. No large human RCTs exist, but the mechanistic rationale and preclinical evidence are well-grounded.

  • NAG has demonstrated attenuation of disease severity in collagen-induced arthritis (CIA) animal models, with reductions in synovial inflammatory cell infiltration and immune cell suppression. A mouse RA model showed lower arthritis scores and improved histopathology with dietary NAG at 0.5% for 56 days.

  • Costra lácteaCientífico

    Topical NAG has been tested in multiple clinical trials for reducing fine lines, wrinkles, and photoaging. Studies in women aged 35–65 showed visible wrinkle reduction, particularly around the eye area, after 8 weeks. A 16-week JAAD-published clinical trial in 45 women (40–65 years) using an 8% NAG neck cream demonstrated significant improvement across all dermatologist-graded aging parameters.

  • Calambres (pierna)Científico

    NAG stimulates fibroblast and keratinocyte synthesis of glycosaminoglycans including hyaluronic acid, which underpins skin plumping and elasticity. Clinical studies have demonstrated increased skin firmness and thickness with topical NAG, and in vitro data confirm upregulation of collagen expression.

  • DifteriaCientífico

    NAG, particularly in poly-NAG nanofiber form, has demonstrated accelerated wound closure in preclinical models. NAG stimulates HA synthesis, a key mediator in the proliferative phase of wound healing. A PubMed review (Toole & Wight, J Biol Chem, 2002 lineage; Pujalte and Bissett, 2007) established glucosamine's role in accelerating wound healing through HA upregulation.

Sistemas Corporales

Sistemas corporales que N-acetil-glucosamina puede ayudar a apoyar.

  • No hay sistemas corporales disponibles.
Únete a nuestro boletín

Mantente informado. Mantente saludable.

Recibe consejos de suplementos de expertos, descuentos exclusivos y recomendaciones de productos en tu bandeja de entrada

N-acetil-glucosamina | Vitabase